Please use this identifier to cite or link to this item: https://ahro.austin.org.au/austinjspui/handle/1/13386
Title: A multicentre double blind trial of fluoxetine versus amitriptyline in the treatment of depressive illness.
Austin Authors: Judd, F K;Moore, K;Norman, Trevor R ;Burrows, Graham D;Gupta, R K;Parker, G
Affiliation: University of Melbourne, Department of Psychiatry, Austin Hospital, Heidelberg, Victoria.
Issue Date: 1-Mar-1993
Publication information: The Australian and New Zealand Journal of Psychiatry; 27(1): 49-55
Abstract: The antidepressant efficacy and side effect profile of a fixed dose of 20 mg/day of fluoxetine, a specific serotonin reuptake inhibitor, were compared to those of amitriptyline. Fifty-eight patients with DSM-III-R depression were randomly assigned to receive either fluoxetine or amitriptyline. Fifty-six patients (fluoxetine N = 23, amitriptyline N = 23) completed the 6 week study. Comparable antidepressant efficacy was demonstrated for the two drugs. Patients taking fluoxetine reported less side-effects than those taking amitriptyline.
Gov't Doc #: 8481170
URI: https://ahro.austin.org.au/austinjspui/handle/1/13386
Journal: The Australian and New Zealand Journal of Psychiatry
URL: https://pubmed.ncbi.nlm.nih.gov/8481170
Type: Journal Article
Subjects: Adult
Amitriptyline.adverse effects.therapeutic use
Depressive Disorder.drug therapy.psychology
Double-Blind Method
Female
Fluoxetine.adverse effects.therapeutic use
Humans
Male
Middle Aged
Personality Inventory
Suicide.prevention & control.psychology
Appears in Collections:Journal articles

Show full item record

Page view(s)

34
checked on Dec 27, 2024

Google ScholarTM

Check


Items in AHRO are protected by copyright, with all rights reserved, unless otherwise indicated.